Phase 3 Clinical Trial of Wujia Yizhi Granules in the Treatment of Mild-to-moderate Alzheimer's Dementia (Syndrome of Deficiency of Spleen and Kidney)
Clinical trial NCT06534723 · RECRUITING
Trial details
- NCT number
- NCT06534723
- Sponsor
- Sichuan Jishengtang Pharmaceutical Co., Ltd.
- Status
- RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2024-08-20
- Primary completion
- 2026-08-31
- Enrollment
- 570
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.